Coloplast A/S (ADR)
General ticker "CLPBY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $22.8B (TTM average)
Coloplast A/S (ADR) does not follow the US Stock Market performance with the rate: -22.4%.
Estimated limits based on current volatility of 1.3%: low 8.67$, high 8.90$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-12-08, amount 0.15$ (Y3.41%)
- Current price 23.1% below estimated low
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [10.57$, 15.87$]
- 2025-09-30 to 2026-09-30 estimated range: [11.45$, 17.03$]
Financial Metrics affecting the CLPBY estimates:
- Positive: with PPE of 41.5 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 27.08 > 18.64
- Negative: Industry operating profit margin (median), % of -8.00 <= 2.97
- Negative: 0 < Industry inventory ratio change (median), % of 0.28
- Positive: 0.33 < Operating cash flow per share per price, % of 1.38
- Negative: Industry operating cash flow per share per price (median), % of 0 <= 5.52
Short-term CLPBY quotes
Long-term CLPBY plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | DKK22,579.00MM | DKK24,500.00MM | DKK27,030.00MM |
| Operating Expenses | DKK16,140.00MM | DKK17,729.00MM | DKK19,710.00MM |
| Operating Income | DKK6,439.00MM | DKK6,771.00MM | DKK7,320.00MM |
| Non-Operating Income | DKK-312.00MM | DKK-746.00MM | DKK-925.00MM |
| Interest Expense | DKK172.00MM | DKK638.00MM | DKK882.00MM |
| R&D Expense | DKK866.00MM | DKK872.00MM | DKK913.00MM |
| Income(Loss) | DKK6,127.00MM | DKK6,025.00MM | DKK6,395.00MM |
| Taxes | DKK1,421.00MM | DKK1,242.00MM | DKK1,343.00MM |
| Profit(Loss)* | DKK2,973.00MM | DKK2,795.00MM | DKK5,052.00MM |
| Stockholders Equity | DKK8,292.00MM | DKK17,299.00MM | DKK17,942.00MM |
| Inventory | DKK3,187.00MM | DKK3,522.00MM | DKK3,672.00MM |
| Assets | DKK34,956.00MM | DKK48,159.00MM | DKK48,073.00MM |
| Operating Cash Flow | DKK5,099.00MM | DKK4,226.00MM | DKK2,766.00MM |
| Capital expenditure | DKK1,135.00MM | DKK1,241.00MM | DKK1,166.00MM |
| Investing Cash Flow | DKK-11,759.00MM | DKK-8,957.00MM | DKK-1,336.00MM |
| Financing Cash Flow | DKK6,591.00MM | DKK5,265.00MM | DKK-1,518.00MM |
| Earnings Per Share** | DKK1.40 | DKK1.30 | DKK2.25 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.